Pullulan and Pharmaceutical intermediates manufacturer

Mimei Biotechnology is a leading pullulan manufacturer and supplier in China. With a registered capital of 15.75 million USD and a planned total investment of 75 million USD, our project covers an area of approximately 14 hectares with a total construction area of 120,000 ㎡, making us one of the larger production bases in China. Our annual production capacity includes 3,000 tons of pullulan, 10 billion hollow pullulan capsules, 80 million pullulan bio-polysaccharide membranes, and 10,800 tons of dextran. Our anticipated annual sales revenue exceeds 120 million USD, contributing over 15 million USD in tax revenue to the national and local governments. Additionally, our company has obtained ISO22000, ISO14001, and ISO45001 quality system certifications..

Our pullulan products have obtained various certifications, including organic, kosher, and halal certifications, among others. These certifications not only attest to the high quality and safety of our products but also demonstrate our firm commitment to product quality and reputation.